Contextualizing and Responding to HIV Risk Behaviors among Black Drug Offenders, New York, 2016 (ICPSR 37590)
The purpose of this study was to pilot test the potential for improvement in antiretroviral medication adherence of an adapted group-based, multi-session, community-based Antiretroviral Therapy (ART) adherence and risk reduction intervention, Project ADHerence Education and Risk Evaluation (ADHERE). Project ADHERE was compared to a single-session group-based medication adherence intervention, Medication Adherence and Care Engagement (MACE). A secondary aim was to examine the impact of Project ADHERE on HIV risk behaviors (i.e., illicit drug use and unprotected sexual behavior).
Formerly incarcerated Black drug offenders are at an elevated risk for HIV infection. Despite substantial research expressing the need for HIV prevention services for ex-offenders postrelease, this population has limited access to quality programming and services related to HIV risk reduction. This study seeks to inform and adapt an HIV risk reduction intervention to address the needs of formerly incarcerated Black drug offenders who are being released from prisons in the New York City metropolitan area. The study utilizes qualitative and quantitative methods to inform and adapt an HIV prevention intervention for this study population.
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): HIV/HEPATITIS Prevention for Re-Entering Drug Offenders (ICPSR 29061)
Criminal Justice Drug Abuse Treatment Studies (CJ-DATS): Performance Indicators for Corrections (PIC), 2002-2006 [United States] (ICPSR 27942)
In 2002, the National Institute on Drug Abuse (NIDA) funded the Criminal Justice Drug Abuse Treatment Studies (CJ-DATS) cooperative agreement. The Institute of Behavioral Research at Texas Christian University (TCU) was one of nine National Research Centers selected to study current drug treatment practices and outcomes in correctional settings and to examine strategies for improving treatment services for drug-involved offenders.
The specific aims of the PIC study were to:
- Cross sectionally test and adapt the TCU CJ-CEST, BOP, and NDRI CAI assessments for use in multiple correctional settings;
- To examine agency and program records of client progress relevant to treatment process; and to
- Revise the assessments as necessary for use in longitudinal assessment protocols and CJ Management Information Systems (MIS).
During the first data collection period, Wave 1, a total of 3,266 inmates were surveyed from research centers based out of Texas Christian University, the University of Delaware, the University of Kentucky, University of California, Los Angeles (UCLA), and the National Development and Research Institute (NDRI). After psychometrics were run and the forms revised slightly, a second administration took place but this time only at two centers (TCU and Delaware). During Wave 2 a total of 1,421 clients participated in the survey.
Finding, Testing and Treating High-Risk Probationers and Parolees with HIV (Urban Health Studies: UHS II), California, 2012-2013 (ICPSR 39801)
The Seek, Test, Treat and Retain (STTR) Collaboration Project involved over twenty studies in the fields of HIV and drug abuse. These studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. These studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (e.g. demographic characteristics, mental health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study. This repository contains the collected data and documentation from the STTR collaboration.
This study in particular is part of the Urban Health Studies project, specifically assessing treatment outcomes of high-risk probationers and parolees with HIV in California from 2012 to 2013.
Multi-site Family Study on Incarceration, Parenting and Partnering, 5 U.S. states, 2008-2014 (ICPSR 36639)
This collection contains data from the Multi-site Family Study on Incarceration, Parenting and Partnering [MSF-IP]. The MSF-IP is an evaluation of a grant program funded by the Office of Family Assistance (OFA) within the U.S. Department of Health and Human Services (HHS), Administration for Children and Families (ACF) to promote or sustain healthy relationships and to strengthen families in which a father was incarcerated or otherwise involved with the criminal justice system (e.g., recently released or on parole or probation). From 2006-2011, grantees were required to serve justice-involved fathers and their committed partners with services to promote healthy marriage; they were also permitted to provide activities to support parenting and foster economic stability.
The MFS-IP evaluation was funded to document program implementation and the impact of programming on outcomes such as relationship quality and stability, parenting and co-parenting, family financial well-being, and recidivism. This collection includes data from the impact study, conducted across five grantees: the Indiana Department of Correction, the RIDGE Project (Ohio), the New Jersey Department of Corrections, the Osborne Association (New York), and the Minnesota Council on Crime and Justice. The collection includes de-identified interview data for 1,991 men and 1,482 intimate and co-parenting partners.
The interviews took place from December 2008 through August 2014. Couples were first interviewed during the male partner's incarceration (with the timing of baseline interviews not related to the man's admission or release date in most sites) and then interviewed again nine and 18 months after baseline. In the two largest sites (Indiana and Ohio), an additional 34-month follow-up interview was conducted. The interviews were similar in content at each interview wave and for the male and female interviews, but differed based on male partner's trajectory of incarceration and release over the follow-up period.
Topics within this collection include demographics, personal characteristics and attitudes, criminal history and behavior, incarceration experiences (including family contact during incarceration), program and service receipt, expectations for release, family structure and functioning, intimate relationship quality, parenting and co-parenting quality, child well-being, employment, housing, substance use, and experiences with reentry.
Naltrexone for Extended-Release Injectable Suspension (XR-NTX) for Opioid Dependent Released HIV-Positive Criminal Justice Populations (Project NEW HOPE), Connecticut and Massachusetts, 2011-2015 (ICPSR 39790)
This study is part of the Seek, Test, Treat and Retain (STTR) Collaboration Project that involved over twenty studies in the fields of HIV and drug abuse. All studies were independently developed, but were chosen for the collaboration because they focused on one or more steps of the HIV treatment cascade: Seek, Test, Treat and Retain. As part of STTR Collaboration Project, the studies were grouped into Criminal Justice-related studies and Vulnerable Population-related studies. The data collected by these studies included twelve common domains (e.g., Demographic characteristics, Mental Health) in each of which a shared questionnaire or instrument was taken up by the studies and adapted to fit the study.
The specific aim for this study was to conduct a placebo-controlled, RCT of VIVITROL or (extended-release naltrexone) (XR-NTX 380mg) among HIV+ persons in jails and prisons meeting DSM-IV criteria for opioid dependence who are transitioning to the community. HIV treatment outcomes (HIV-1 RNA levels, CD4 count, HAART adherence, retention in care), substance abuse (time to relapse to opioid use, % opioid negative urines, opioid craving), adverse side effects and HIV risk behavior (sexual and drug-related risks) outcomes were compared in 150 recruited prisoners and jail detainees in CT and MA who were randomized 2:1 to either XR-NTX 380mg or XR-NTX-placebo. The primary outcome of interest was the proportion with a HIV-RNA less than 400 copies/mL at 6 months. Secondary outcomes included mean CD4 count, antiretroviral adherence, retention on HAART and in HIV care, HIV risk behaviors, time-to-relapse to opioid use, percent opioid negative urines, retention on XR-NTX 380mg and HIV quality of life. Primary and secondary outcomes were assessed for an additional 6 months after completion of the intervention.